PhRMA federal legislation division
Executive Summary
Michael Reed, previously VP-government relations, to newly created post of senior legislative counsel in a reorganization of the federal legislation division announced May 9 by newly hired Executive VP-Strategic and Legislative Affairs Stephen Conafay. Deputy VP-Government Relations Lynda Nersesian will retain her title, as will legislative counsels Albert Saunders and Jeffrey Anders. Reed and Nersesian both will report to Conafay. Lara Robillaird -- formerly with Jones, Day, Reavis and Pogue, where Conafay held an of-counsel position before coming to PhRMA -- will join PhRMA as federal legislation associate. In announcing the changes, Conafay declares his intention to take an active, personal role in lobbying: "Mike Reed is one of the most respected and best-liked members of the legislative community, but I want to be directly involved in the daily federal legislative decisions and activities of PhRMA
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: